News Archives

News Archives

Avivagen Announces Vivamune Distribution Agreement for the GTA

Ottawa, ON / TNW-Accesswire / August 22, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that it has entered into a …Read More

Avivagen Announces Agreement to Terminate China JV

Ottawa, ON / TNW-Accesswire / August 07, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that it has entered into an agreement that will …Read More

Avivagen Receives Approval from Health Canada for Use of OxC-beta™ in Companion Animal Supplements

Ottawa, ON / TNW-Accesswire / June 27, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that the Veterinary Drugs Directorate of …Read More

Avivagen Announces Largest Order To-Date for OxC-beta™ Livestock

Ottawa, ON / TNW-Accesswire / June 25, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that its partner in the Philippines, …Read More

Avivagen to Exhibit Vivamune at SuperZoo

Ottawa, ON / TNW-Accesswire / June 22, 2018 / – – Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that it will be exhibiting Vivamune …Read More

Avivagen Announces Distribution Agreement in Thailand

Ottawa, ON / TNW-Accesswire / June 13, 2018 / – Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that it has signed a distribution agreement …Read More